Stock A001630 CHONG KUN DANG HOLDINGS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chong Kun Dang Holdings Corp.

Equities

A001630

KR7001630003

Food Processing

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 03/05/2024 am IST 		5-day change 1st Jan Change
62,000 KRW +0.32% Intraday chart for Chong Kun Dang Holdings Corp. +0.81% +4.73%
06/02 Tranche Update on Chong Kun Dang Holdings Corp.'s Equity Buyback Plan announced on August 12, 2022. CI
06/02 Tranche Update on Chong Kun Dang Holdings Corp.'s Equity Buyback Plan announced on August 12, 2022. CI

Business Summary

CHONGKUNDANG HOLDINGS CORP., formerly Chong Kun Dang Pharmaceutical Corp., is a Korea-based company engaged in the investment business. Through its subsidiary, the Company provides pharmaceuticals, including remedies for high blood pressure and high cholesterol, immunosuppressive drugs, antitumor agents, antibiotics, remedies for erectile dysfunction and remedies for obesity. It also produces antitumor agents, antibiotics, digestives, circulation agents, respiratory agents, remedies for endocrine diseases, remedies for skin diseases, functional cosmetics and others, as well as pharmaceutical ingredients. On November 2, 2013, the Company divested its pharmaceutical business into a newly established wholly owned subsidiary. After the divestiture, the Company engages in the investment and holding business.

Number of employees: 38

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medicine
96.3 %
897,366 98.7 % 846,810 96.3 % -5.63%
Others
7.3 %
62,071 6.8 % 64,548 7.3 % +3.99%
Consolidated Adjustment
-3.6 %
-50,474 -5.6 % -31,577 -3.6 % -37.44%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
82.4 %
761,452 84.8 % 724,596 82.4 % -4.84%
Asia
8.7 %
96,701 10.8 % 76,151 8.7 % -21.25%
Europe
6.4 %
37,364 4.2 % 56,279 6.4 % +50.62%
Other
3.9 %
34,779 3.9 % 34,469 3.9 % -0.89%
Consolidated Adjustment
-2.8 %
-39,133 -4.4 % -24,738 -2.8 % -36.79%
Middle East
1.5 %
6,793 0.8 % 12,902 1.5 % +89.94%

Managers

Managers TitleAgeSince
Sang-Yeon Hwang CEO
 Chief Executive Officer 53 -
Jang-Won Choi BRD
 Director/Board Member 62 -
Ja-Min Gu BRD
 Director/Board Member 60 -
Jae-Hoon Yoon HRO
 Human Resources Officer 58 -
Seong-Wook Han PRN
 Corporate Officer/Principal 53 01/10/01
Yoon-Han Lee AUD
 Comptroller/Controller/Auditor 65 01/03/01
Jang-Han Lee PRN
 Corporate Officer/Principal 71 -

Members of the board

Members of the board TitleAgeSince
Jang-Han Lee PRN
 Corporate Officer/Principal 71 -
Sang-Yeon Hwang CEO
 Chief Executive Officer 53 -
Ja-Min Gu BRD
 Director/Board Member 60 -
Jang-Won Choi BRD
 Director/Board Member 62 -
Jae-Hoon Yoon HRO
 Human Resources Officer 58 -
Chun-Soon Kim BRD
 Director/Board Member 61 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,009,861 2,387,246 ( 47.65 %) 249,303 ( 4.976 %) 47.65 %

Shareholders

NameEquities%Valuation
Jang-Han Lee
33.73 %
1,689,586 33.73 % 75 M ₩
Jae-jung Chung
5.820 %
291,575 5.820 % 13 M ₩
National Pension Service of Korea
5.335 %
267,292 5.335 % 12 M ₩
CHONG KUN DANG HOLDINGS CORP.
3.146 %
157,604 3.146 % 7 M ₩
Joo-won Rhee
2.892 %
144,867 2.892 % 6 M ₩
Joo-ah Rhee
2.588 %
129,650 2.588 % 6 M ₩
Joo-gyung Rhee
2.551 %
127,780 2.551 % 6 M ₩
APS Asset Management Pte Ltd.
0.1653 %
8,279 0.1653 % 367 136 ₩
Mackenzie Investments Corp. (United States)
0.1346 %
6,742 0.1346 % 298 977 ₩
KB Asset Management Co. Ltd.
0.1344 %
6,733 0.1344 % 298 578 ₩

Holdings

NameEquities%Valuation
CHONG KUN DANG PHARMACEUTICAL CORP.
25.44%
 3,352,101 25.44% 274,392,965 $
KYONGBO PHARMACEUTICAL CO., LTD
43.41%
 10,377,045 43.41% 57,242,063 $
CKD BIO CORP.
39.11%
 2,145,328 39.11% 38,165,728 $
CHONG KUN DANG HOLDINGS CORP.
3.15%
 157,604 3.15% 6,989,012 $
DAIHAN PHARMACEUTICAL CO.,LTD.
1.56%
 93,802 1.56% 1,971,846 $

Company contact information

ChongKunDang Holdings Corp.

8 Chungjeong-ro Seodaemun-gu

03742, Seoul

+

http://www.ckd-holdings.com
address Chong Kun Dang Holdings Corp.(A001630)

Sector

Consumer Non-Cyclicals
Food & Beverages
Food & Tobacco
Food Processing
Special Foods & Wellbeing Products

Sales per Business

Sales per region

Ratings for Chong Kun Dang Holdings Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
62,000 KRW
Average target price
63,000 KRW
Spread / Average Target
+1.61%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
CHONG KUN DANG HOLDINGS CORP. Stock Chong Kun Dang Holdings Corp.
+4.73% 218M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+13.21% 8.15B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+3.16% 7.52B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+12.30% 6.65B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-5.71% 3.73B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-6.99% 3.72B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-4.78% 1.31B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+12.61% 972M
HERBALIFE LTD. Stock Herbalife Ltd.
-37.22% 958M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-15.02% 876M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. A001630 Stock
  4. Company Chong Kun Dang Holdings Corp.